Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Additional file 5 of Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

  • Osman Öcal (Creatore)
  • Regina Schinner (Creatore)
  • Kerstin Schütte (Creatore)
  • Enrico N. De Toni (Creatore)
  • Christian Loewe (Creatore)
  • Otto van Delden (Creatore)
  • Vincent Vandecaveye (Creatore)
  • Bernhard Gebauer (Creatore)
  • Christoph J Zech (Creatore)
  • Christian Sengel (Creatore)
  • Irene Bargellini (Creatore)
  • Antonio Gasbarrini (Creatore)
  • Bruno Sangro (Creatore)
  • Maciej Pech (Creatore)
  • Peter Malfertheiner (Creatore)
  • Jens Ricke (Creatore)
  • Max Seidensticker (Creatore)

Dataset

Description

Additional file 5: Supplementary Fig. 5. Overall survival of patients according to best response. BR, best response; CI, confidence interval; CR, complete response; HR, hazard ratio; PR, partial response; PD, progressive disease; SD, stable disease.
Dati resi disponibili2022
Editorefigshare

Cita questo